Patients with symptomatic internal carotid artery (ICA) occlusion with haemodynamic impairment are at higher risk of ischaemic stroke, and they require treatment. There are two main options: the best medical treatment and an extracranial-intracranial bypass. The aims of this study are to analyse the 30-day and 2-year risk of stroke and death in patients with extracranial-intracranial bypass performed by our department and to compare our results with major published studies. This retrospective study enrolled patients who underwent surgery from 1998 to 2012. Inclusion criteria were the following: (1) radiological diagnosis of symptomatic atherosclerotic internal carotid artery occlusion (AICAO), (2) less than 50 % stenosis of a contralateral ICA, (3) transient ischaemic attack (TIA) or ischaemic stroke in the hemispheric territory on an occluded side within 120 days and (4) haemodynamic impairment of at least stage I according to transcranial Doppler sonography (TCDS), perfusion CT and SPECT. Patients were followed up in the outpatient department with TCDS and sonography of the contralateral ICA and the anastomosis after 6 weeks and every 12 months after that. All risks of stroke and death from surgery were recorded throughout the 30 days and the following 2 years post surgery. From September 1998 to November 2012, 93 patients were selected for bypass surgery. There were 72 men and 21 women in an age range of 33 to 79 years (mean 58.9 years) and a follow-up range of 13 to 187 months (mean 108 months). The 30-day risk of stroke and death was 7.5 %. It consists of one death, one major ischaemic stroke, two reversible neurological deficits and three TIAs. The 2-year risk of stroke and death was 9.7 %. Extracranial-intracranial bypass is an effective treatment of haemodynamic impairment in patients with internal carotid occlusion. Maintaining low-level morbidity and mortality is possible with a dedicated neurovascular team. This is the only way in which we can reduce the risk of stroke and death in patients with bypass compared to patients treated medically.

Department of Neurosurgery J E Purkinje University and Masaryk Hospital Socialni pece 3316 12A 40113 Usti nad Labem Czech Republic

Zobrazit více v PubMed

J Neurosurg. 2013 Jan;118(1):20-2; discussion 22-4 PubMed

J Neurosurg. 1994 Aug;81(2):236-44 PubMed

J Neurosurg. 1976 Mar;44(3):313-24 PubMed

Neurology. 1984 Sep;34(9):1168-74 PubMed

Neurology. 1999 Jul 22;53(2):251-9 PubMed

N Engl J Med. 1987 Mar 26;316(13):814-6 PubMed

Surg Neurol. 1986 Sep;26(3):218-21 PubMed

JAMA. 1998 Sep 23-30;280(12 ):1055-60 PubMed

Stroke. 1985 Jul-Aug;16(4):609-16 PubMed

J Neurosurg. 2013 Jan;118(1):25-33 PubMed

Stroke. 2009 Apr;40(4):1405-9 PubMed

Mayo Clin Proc. 1985 Apr;60(4):230-40 PubMed

J Neurosurg. 1985 Jun;62(6):831-8 PubMed

N Engl J Med. 1985 Nov 7;313(19):1191-200 PubMed

Neurosurgery. 2012 Sep;71(3):557-61 PubMed

Neurol Res. 1983;5(2):1-9 PubMed

Lancet. 2014 Jan 25;383(9914):333-41 PubMed

JAMA. 2011 Nov 9;306(18):1983-92 PubMed

N Engl J Med. 1987 Mar 26;316(13):817-20 PubMed

Neurosurgery. 1977 Jul-Aug;1(1):22-4 PubMed

Stroke. 2011 Dec;42(12 ):3637-9 PubMed

J Neurosurg. 2005 Nov;103(5):794-804 PubMed

Stroke. 1981 Jul-Aug;12(4):454-9 PubMed

Stroke. 1992 Feb;23 (2):171-4 PubMed

Neurosurgery. 1984 Dec;15(6):787-94 PubMed